Professor Martin Gore
- Medical Director
Professor Martin Gore is the Medical Director of The Royal Marsden and Professor of Cancer Medicine at The Institute of Cancer Research. He qualified in medicine at St Bartholomew’s Hospital, London, and spent time in general practice before training in general internal medicine at University College Hospital, London. He joined the Ludwig Institute of Cancer Research in 1981 where he worked as a clinical scientist and was awarded a PhD for his work on breast cancer.
Professor Gore was a founder Senior Investigator of the National Institute for Health Research and has recently stepped down from being Chairman of the Department of Health’s Gene Therapy Advisory Committee. He is a past President of the UK Melanoma Study Group and a past Chair of the National Cancer Research Institute’s Melanoma Clinical Studies Group.
He has served on the Health and Safety Executive’s Scientific Advisory Committee on Genetically Modified Organisms, the Council of the International Gynaecologic Cancer Society, the Programme Committee of the Annual Meeting of the American Society of Clinical Oncology and he was co-founder of the European International Kidney Cancer Symposium. He is a Medical Advisor to the US-based patient advocacy group the Kidney Cancer Association and Patron of the Rarer Cancers Foundation.
He is the editor of the Gynaecological Cancer Section of Current Opinion in Oncology and has served on the editorial board of several journals including the Journal of Clinical Oncology. He has published over 400 articles and edited eight textbooks.
Professor Gore’s main research interests are the development of novel therapeutics in ovarian cancer, melanoma and renal cell carcinoma, particularly in the area of biologics, gene therapy and targeted agents.